ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraaknorsk 
    • EnglishEnglish
    • norsknorsk
  • Administrasjon/UB
Vis innførsel 
  •   Hjem
  • Universitetsbiblioteket
  • Artikler, rapporter og annet (UB)
  • Vis innførsel
  •   Hjem
  • Universitetsbiblioteket
  • Artikler, rapporter og annet (UB)
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Altered fractionation short-course radiotherapy for stage II-III rectal cancer: A retrospective study

Permanent lenke
https://hdl.handle.net/10037/18944
DOI
https://doi.org/10.1186/s13014-020-01566-8
Thumbnail
Åpne
article.pdf (1010.Kb)
Publisert versjon (PDF)
Dato
2020-05-14
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Forfatter
Geinitz, Hans; Nieder, Carsten; Kocik, Lukas; Track, Christine; Feichtinger, Johann; Weingartner, Theresa; Spiegl, Kurt J.; Füreder-Kitzmüller, Barbara; Kaufmann, Johanna; Seewald, Dietmar H.; Függer, Reinhold; Shamiyeh, Andreas; Petzer, Andreas L.; Kiesl, David; Hammer, Josef
Sammendrag
Purpose: To report the long-term outcomes of neoadjuvant altered fractionation short-course radiotherapy in 271 consecutive patients with stage II-III rectal cancer.

Patients and Methods: This was a retrospective single institution study with median follow-up of 101 months (8.4 years). Patients who were alive at the time of analysis in 2018 were contacted to obtain functional outcome data (phone interview). Radiotherapy consisted of 25 Gy in 10 fractions of 2.5 Gy administered twice daily. Median time interval to surgery was 5 days.

Results: Local relapse was observed in 12 patients (4.4%) after a median of 28 months. Overall survival after 5 and 10 years was 73 and 55.5%, respectively (corresponding disease-free survival 65.5 and 51%). Of all patients without permanent stoma, 79% reported no low anterior resection syndrome (LARS; 0–20 points), 9% reported LARS with 21–29 points and 12% serious LARS (30–42 points).

Conclusion: The present radiotherapy regimen was feasible and resulted in low rates of local relapse. Most patients reported good functional outcomes.

Forlag
BMC
Sitering
Geinitz, Nieder, Kocik, Track, Feichtinger, Weingartner, Spiegl, Füreder-Kitzmüller, Kaufmann, Seewald, Függer, Shamiyeh, Petzer, Kiesl, Hammer. Altered fractionation short-course radiotherapy for stage II-III rectal cancer: A retrospective study. Radiation Oncology. 2020;15
Metadata
Vis full innførsel
Samlinger
  • Artikler, rapporter og annet (UB) [3245]
Copyright 2020 The Author(s)

Bla

Bla i hele MuninEnheter og samlingerForfatterlisteTittelDatoBla i denne samlingenForfatterlisteTittelDato
Logg inn

Statistikk

Antall visninger
UiT

Munin bygger på DSpace

UiT Norges Arktiske Universitet
Universitetsbiblioteket
uit.no/ub - munin@ub.uit.no

Tilgjengelighetserklæring